Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
about
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancerCRISPR/Cas9: Transcending the Reality of Genome Editing.Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.Clinical and biological significance of PIM1 kinase in osteosarcoma.CRISPR/Cas9n-Mediated Deletion of the Snail 1Gene (SNAI1) Reveals Its Role in Regulating Cell Morphology, Cell-Cell Interactions, and Gene Expression in Ovarian Cancer (RMG-1) CellsCharacterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to PaclitaxelThe CRISPR/Cas9 system for gene editing and its potential application in pain researchAndrogen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.Inhibitors of cyclin-dependent kinases as cancer therapeutics.Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regressionAll-in-One CRISPR-Cas9/FokI-dCas9 Vector-Mediated Multiplex Genome Engineering in Cultured Cells.Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma
P2860
Q26751387-6FFAED93-83EB-4F57-9F30-35DEDF776822Q33632925-1F82DB48-8B1A-4817-868D-422332F7FB3EQ34045952-3C95DC7E-5254-4A5B-A59E-53E87779A7D5Q34674917-9FB02FEE-82C5-4BCC-A661-4A70CF099610Q35687948-3C6B3CAA-92A4-49DB-B1AE-7C3674D81749Q36905783-CD3E5114-5C6E-4AC1-8418-22FA52429918Q37075249-03AFCF6B-381D-458A-9D6D-AB1E20DD2D68Q37148023-14C7C846-7120-4140-82C2-FC502CEAB852Q37682137-16D5DE32-CEF4-47A8-8DB1-54F2216F4D46Q38669852-538A33C3-4970-4127-B963-C277CBF4DB24Q39125016-8282AF06-5C22-4E1D-BA2D-B8F72BE7A909Q39319380-BA548AFA-FBF1-4FC9-848D-395AF2EA2D66Q41511092-83DE3F9F-123D-49D4-980F-FB82F753038FQ50576098-4844D7F9-5E4D-4710-A024-9EA94F3EE9D6Q58554623-CDB9CA01-6F59-4AB2-B824-33840F2E6B3D
P2860
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
@ast
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
@en
type
label
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
@ast
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
@en
prefLabel
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
@ast
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
@en
P2093
P2860
P356
P1476
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
@en
P2093
Eiji Osaka
Francis J Hornicek
Henry J Mankin
Jacson K Shen
Jianming Zhang
Shuhua Yang
Slim Sassi
Xiaoqian Yang
P2860
P304
P356
10.1002/JOR.22745
P577
2014-10-27T00:00:00Z